| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 30 | 2024 | 3250 | 6.070 |
Why?
|
| Neurology | 20 | 2023 | 786 | 4.730 |
Why?
|
| Neuromyelitis Optica | 10 | 2024 | 266 | 4.450 |
Why?
|
| Nervous System Diseases | 20 | 2023 | 1661 | 4.070 |
Why?
|
| Epilepsy | 28 | 2024 | 3327 | 3.550 |
Why?
|
| Refugees | 11 | 2024 | 615 | 3.290 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 6 | 2021 | 68 | 2.750 |
Why?
|
| Developing Countries | 19 | 2022 | 2913 | 2.630 |
Why?
|
| Demyelinating Diseases | 4 | 2023 | 358 | 2.550 |
Why?
|
| Altruism | 6 | 2019 | 211 | 1.930 |
Why?
|
| Internationality | 7 | 2021 | 1008 | 1.750 |
Why?
|
| Stroke | 17 | 2022 | 9755 | 1.600 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 4 | 2021 | 133 | 1.510 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2018 | 1165 | 1.430 |
Why?
|
| Guinea | 12 | 2024 | 33 | 1.380 |
Why?
|
| World Health Organization | 5 | 2021 | 1328 | 1.250 |
Why?
|
| Bhutan | 13 | 2024 | 61 | 1.250 |
Why?
|
| Fluoxetine | 3 | 2021 | 733 | 1.240 |
Why?
|
| Financial Management | 2 | 2022 | 161 | 1.120 |
Why?
|
| Income | 6 | 2022 | 1878 | 1.100 |
Why?
|
| Brain Ischemia | 8 | 2020 | 3007 | 1.070 |
Why?
|
| Seizures | 8 | 2024 | 2998 | 1.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2022 | 558 | 1.030 |
Why?
|
| Humans | 207 | 2024 | 767991 | 1.020 |
Why?
|
| Education, Medical | 6 | 2018 | 1742 | 1.000 |
Why?
|
| Educational Status | 5 | 2024 | 2515 | 0.970 |
Why?
|
| Adult | 95 | 2024 | 223583 | 0.900 |
Why?
|
| Paralysis | 3 | 2013 | 250 | 0.850 |
Why?
|
| Social Stigma | 5 | 2021 | 788 | 0.850 |
Why?
|
| Anticonvulsants | 7 | 2024 | 1922 | 0.830 |
Why?
|
| Familial Mediterranean Fever | 1 | 2023 | 65 | 0.820 |
Why?
|
| Female | 118 | 2024 | 397113 | 0.820 |
Why?
|
| Immunologic Factors | 4 | 2022 | 1594 | 0.820 |
Why?
|
| Middle Aged | 85 | 2024 | 223422 | 0.810 |
Why?
|
| HIV Seronegativity | 2 | 2013 | 210 | 0.790 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2024 | 263 | 0.790 |
Why?
|
| Population Surveillance | 4 | 2021 | 2594 | 0.790 |
Why?
|
| Poverty | 7 | 2024 | 2720 | 0.780 |
Why?
|
| Aquaporin 4 | 4 | 2024 | 161 | 0.750 |
Why?
|
| Male | 107 | 2024 | 364641 | 0.750 |
Why?
|
| Brain | 17 | 2024 | 27366 | 0.730 |
Why?
|
| Meningitis, Meningococcal | 1 | 2021 | 43 | 0.730 |
Why?
|
| Depression | 8 | 2023 | 8231 | 0.720 |
Why?
|
| Health Services Accessibility | 8 | 2019 | 5520 | 0.720 |
Why?
|
| Clarithromycin | 1 | 2021 | 87 | 0.720 |
Why?
|
| Central Nervous System Diseases | 3 | 2021 | 519 | 0.710 |
Why?
|
| Employment | 2 | 2024 | 1110 | 0.690 |
Why?
|
| Tanzania | 6 | 2022 | 1407 | 0.680 |
Why?
|
| Young Adult | 40 | 2024 | 60048 | 0.660 |
Why?
|
| Academies and Institutes | 2 | 2015 | 326 | 0.650 |
Why?
|
| Aged | 65 | 2024 | 171446 | 0.640 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.640 |
Why?
|
| Cognition Disorders | 6 | 2018 | 3977 | 0.630 |
Why?
|
| Relief Work | 1 | 2020 | 131 | 0.620 |
Why?
|
| Susac Syndrome | 2 | 2023 | 22 | 0.610 |
Why?
|
| Fasciculation | 2 | 2008 | 9 | 0.600 |
Why?
|
| Hallucinations | 1 | 2021 | 373 | 0.600 |
Why?
|
| Central Nervous System Infections | 3 | 2014 | 61 | 0.600 |
Why?
|
| Phototherapy | 2 | 2020 | 368 | 0.600 |
Why?
|
| Rural Population | 8 | 2019 | 2325 | 0.590 |
Why?
|
| Autoantibodies | 6 | 2024 | 2117 | 0.590 |
Why?
|
| HIV Infections | 10 | 2021 | 17569 | 0.590 |
Why?
|
| Paresthesia | 2 | 2009 | 160 | 0.590 |
Why?
|
| Areca | 1 | 2017 | 11 | 0.590 |
Why?
|
| Adolescent | 40 | 2024 | 89155 | 0.580 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2024 | 36742 | 0.580 |
Why?
|
| Arsenic | 2 | 2020 | 358 | 0.580 |
Why?
|
| Curriculum | 5 | 2023 | 3782 | 0.580 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 966 | 0.570 |
Why?
|
| Splenectomy | 1 | 2019 | 392 | 0.570 |
Why?
|
| Cost of Illness | 3 | 2020 | 1951 | 0.570 |
Why?
|
| Mastication | 1 | 2017 | 53 | 0.560 |
Why?
|
| Anecdotes as Topic | 3 | 2005 | 56 | 0.560 |
Why?
|
| Neck Pain | 2 | 2009 | 191 | 0.560 |
Why?
|
| Health Services Needs and Demand | 6 | 2019 | 1406 | 0.550 |
Why?
|
| Delivery of Health Care | 4 | 2020 | 5366 | 0.550 |
Why?
|
| Encephalitis | 1 | 2021 | 441 | 0.550 |
Why?
|
| Stereotyping | 2 | 2016 | 241 | 0.540 |
Why?
|
| Career Choice | 3 | 2015 | 769 | 0.530 |
Why?
|
| Brain Death | 3 | 2015 | 359 | 0.530 |
Why?
|
| Diphtheria | 2 | 2013 | 32 | 0.530 |
Why?
|
| Health Personnel | 4 | 2023 | 3385 | 0.520 |
Why?
|
| Charities | 1 | 2016 | 35 | 0.510 |
Why?
|
| Walking | 2 | 2021 | 1201 | 0.510 |
Why?
|
| Health Resources | 4 | 2019 | 950 | 0.510 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 1666 | 0.510 |
Why?
|
| Muscle Weakness | 2 | 2009 | 412 | 0.510 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2017 | 1481 | 0.500 |
Why?
|
| Herpesvirus 2, Human | 2 | 2014 | 191 | 0.500 |
Why?
|
| United Nations | 4 | 2022 | 151 | 0.500 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2015 | 62 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 4055 | 0.490 |
Why?
|
| Recovery of Function | 3 | 2021 | 2981 | 0.490 |
Why?
|
| Jordan | 4 | 2020 | 73 | 0.480 |
Why?
|
| Aged, 80 and over | 30 | 2021 | 59598 | 0.480 |
Why?
|
| Motor Activity | 2 | 2019 | 2711 | 0.480 |
Why?
|
| Disasters | 2 | 2011 | 521 | 0.470 |
Why?
|
| Mandatory Programs | 1 | 2015 | 86 | 0.470 |
Why?
|
| Quality of Life | 7 | 2021 | 13489 | 0.470 |
Why?
|
| Fatigue | 3 | 2020 | 1557 | 0.470 |
Why?
|
| Tropical Medicine | 1 | 2015 | 52 | 0.460 |
Why?
|
| Electroencephalography | 9 | 2023 | 6311 | 0.460 |
Why?
|
| Retrospective Studies | 33 | 2024 | 81746 | 0.460 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2011 | 716 | 0.460 |
Why?
|
| Neglected Diseases | 1 | 2015 | 67 | 0.460 |
Why?
|
| Referral and Consultation | 3 | 2019 | 3619 | 0.450 |
Why?
|
| Fibrinolytic Agents | 4 | 2019 | 2080 | 0.450 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 780 | 0.440 |
Why?
|
| Peripheral Nervous System | 1 | 2015 | 151 | 0.440 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2014 | 65 | 0.430 |
Why?
|
| JC Virus | 3 | 2021 | 87 | 0.430 |
Why?
|
| Corynebacterium diphtheriae | 1 | 2013 | 21 | 0.430 |
Why?
|
| Spinal Cord | 3 | 2017 | 1811 | 0.430 |
Why?
|
| Canada | 7 | 2020 | 2129 | 0.420 |
Why?
|
| Electromyography | 2 | 2008 | 1399 | 0.410 |
Why?
|
| Health Policy | 3 | 2023 | 2698 | 0.410 |
Why?
|
| Feasibility Studies | 1 | 2024 | 5314 | 0.410 |
Why?
|
| International Agencies | 1 | 2013 | 244 | 0.410 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2012 | 24 | 0.410 |
Why?
|
| Weight Loss | 1 | 2024 | 2721 | 0.410 |
Why?
|
| Plasmapheresis | 2 | 2021 | 206 | 0.410 |
Why?
|
| Meningitis, Viral | 2 | 2013 | 50 | 0.410 |
Why?
|
| Organizational Policy | 1 | 2015 | 435 | 0.410 |
Why?
|
| Cause of Death | 5 | 2021 | 3720 | 0.410 |
Why?
|
| Medication Adherence | 2 | 2021 | 2187 | 0.400 |
Why?
|
| Medical Oncology | 2 | 2020 | 2341 | 0.400 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 61 | 0.400 |
Why?
|
| Brain Injuries | 3 | 2018 | 2057 | 0.400 |
Why?
|
| Spinal Cord Ischemia | 2 | 2010 | 94 | 0.400 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2012 | 664 | 0.390 |
Why?
|
| Body Height | 1 | 2018 | 1565 | 0.390 |
Why?
|
| Brain Diseases | 2 | 2011 | 1554 | 0.380 |
Why?
|
| AIDS Dementia Complex | 1 | 2012 | 154 | 0.380 |
Why?
|
| School Health Services | 1 | 2015 | 388 | 0.380 |
Why?
|
| Headache | 3 | 2008 | 1263 | 0.380 |
Why?
|
| Polyneuropathies | 1 | 2013 | 139 | 0.380 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1804 | 0.380 |
Why?
|
| Neoplasms | 6 | 2022 | 22365 | 0.370 |
Why?
|
| Schools, Medical | 1 | 2018 | 882 | 0.370 |
Why?
|
| Physician's Role | 3 | 2007 | 925 | 0.370 |
Why?
|
| Catha | 1 | 2010 | 9 | 0.370 |
Why?
|
| Plasma Exchange | 2 | 2012 | 159 | 0.370 |
Why?
|
| Child | 27 | 2024 | 80906 | 0.370 |
Why?
|
| Africa | 4 | 2015 | 725 | 0.360 |
Why?
|
| Autoimmunity | 1 | 2019 | 1361 | 0.360 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2420 | 0.360 |
Why?
|
| Cohort Studies | 16 | 2024 | 41749 | 0.360 |
Why?
|
| Social Support | 6 | 2022 | 2193 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7445 | 0.360 |
Why?
|
| Thrombolytic Therapy | 2 | 2018 | 2055 | 0.360 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 879 | 0.360 |
Why?
|
| Treatment Outcome | 19 | 2022 | 65364 | 0.350 |
Why?
|
| Health Expenditures | 3 | 2020 | 2389 | 0.350 |
Why?
|
| Persistent Vegetative State | 1 | 2013 | 274 | 0.350 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2010 | 26 | 0.340 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2011 | 127 | 0.340 |
Why?
|
| Reproductive Medicine | 1 | 2011 | 99 | 0.340 |
Why?
|
| Death, Sudden | 1 | 2012 | 301 | 0.340 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2015 | 997 | 0.330 |
Why?
|
| Wernicke Encephalopathy | 1 | 2009 | 29 | 0.330 |
Why?
|
| Indians, North American | 2 | 2017 | 354 | 0.330 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4351 | 0.330 |
Why?
|
| Patients | 1 | 2016 | 908 | 0.330 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2024 | 667 | 0.330 |
Why?
|
| Exodeoxyribonucleases | 1 | 2010 | 191 | 0.320 |
Why?
|
| Biomedical Research | 2 | 2019 | 3463 | 0.320 |
Why?
|
| Registries | 4 | 2019 | 8377 | 0.320 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2008 | 1085 | 0.320 |
Why?
|
| Transplants | 1 | 2011 | 208 | 0.320 |
Why?
|
| Stereotyped Behavior | 1 | 2009 | 133 | 0.320 |
Why?
|
| Ethics, Medical | 2 | 2011 | 785 | 0.310 |
Why?
|
| Vertebral Artery Dissection | 1 | 2009 | 48 | 0.310 |
Why?
|
| Needlestick Injuries | 1 | 2008 | 71 | 0.310 |
Why?
|
| Compulsive Behavior | 1 | 2009 | 117 | 0.310 |
Why?
|
| Earthquakes | 1 | 2011 | 192 | 0.310 |
Why?
|
| Health Education | 1 | 2015 | 1059 | 0.300 |
Why?
|
| Human Rights | 1 | 2011 | 312 | 0.300 |
Why?
|
| Neurologic Examination | 4 | 2015 | 914 | 0.300 |
Why?
|
| Autopsy | 1 | 2012 | 1011 | 0.300 |
Why?
|
| Basal Ganglia Diseases | 1 | 2008 | 145 | 0.300 |
Why?
|
| Neuroanatomy | 1 | 2008 | 73 | 0.290 |
Why?
|
| Emergencies | 2 | 2014 | 1224 | 0.290 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2009 | 113 | 0.290 |
Why?
|
| Iraq | 3 | 2012 | 93 | 0.290 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2007 | 8 | 0.290 |
Why?
|
| Syria | 2 | 2020 | 86 | 0.280 |
Why?
|
| Child, Preschool | 15 | 2019 | 42665 | 0.280 |
Why?
|
| Retina | 1 | 2018 | 2662 | 0.280 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2011 | 340 | 0.280 |
Why?
|
| Public Policy | 1 | 2011 | 552 | 0.280 |
Why?
|
| Megestrol Acetate | 1 | 2006 | 18 | 0.270 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1667 | 0.270 |
Why?
|
| Microcephaly | 1 | 2010 | 426 | 0.270 |
Why?
|
| Migraine with Aura | 1 | 2009 | 204 | 0.270 |
Why?
|
| Neurobiology | 1 | 2007 | 135 | 0.270 |
Why?
|
| Professional Practice Location | 1 | 2006 | 57 | 0.260 |
Why?
|
| World War I | 1 | 2006 | 14 | 0.260 |
Why?
|
| Mental Competency | 1 | 2007 | 179 | 0.260 |
Why?
|
| Aging | 5 | 2019 | 8744 | 0.260 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 936 | 0.260 |
Why?
|
| Poetry as Topic | 1 | 2006 | 17 | 0.260 |
Why?
|
| Neuromuscular Diseases | 1 | 2009 | 260 | 0.260 |
Why?
|
| Imagination | 1 | 2007 | 226 | 0.260 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 746 | 0.260 |
Why?
|
| Steroids | 1 | 2011 | 938 | 0.260 |
Why?
|
| Poverty Areas | 1 | 2007 | 268 | 0.260 |
Why?
|
| Carcinoma, Small Cell | 1 | 2008 | 419 | 0.260 |
Why?
|
| Chloroquine | 1 | 2007 | 276 | 0.260 |
Why?
|
| Medicine in Literature | 1 | 2006 | 32 | 0.260 |
Why?
|
| Nucleus Accumbens | 1 | 2008 | 358 | 0.260 |
Why?
|
| Cross-Sectional Studies | 12 | 2023 | 26375 | 0.260 |
Why?
|
| Anorexia | 1 | 2006 | 153 | 0.250 |
Why?
|
| Africa South of the Sahara | 2 | 2021 | 752 | 0.250 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 843 | 0.250 |
Why?
|
| Arm | 1 | 2009 | 591 | 0.250 |
Why?
|
| Risk Factors | 16 | 2019 | 74936 | 0.250 |
Why?
|
| Visitors to Patients | 1 | 2005 | 36 | 0.250 |
Why?
|
| Neurocysticercosis | 2 | 2017 | 91 | 0.250 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 550 | 0.250 |
Why?
|
| Immunocompromised Host | 2 | 2021 | 863 | 0.240 |
Why?
|
| Myasthenia Gravis | 1 | 2008 | 214 | 0.240 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 490 | 0.240 |
Why?
|
| Pulmonary Edema | 1 | 2008 | 408 | 0.240 |
Why?
|
| Philosophy, Medical | 1 | 2005 | 78 | 0.240 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 2957 | 0.240 |
Why?
|
| Students, Medical | 3 | 2008 | 1963 | 0.240 |
Why?
|
| Disability Evaluation | 4 | 2024 | 1835 | 0.240 |
Why?
|
| Cerebrovascular Disorders | 2 | 2012 | 1484 | 0.240 |
Why?
|
| Retinal Vessels | 1 | 2010 | 864 | 0.230 |
Why?
|
| Pandemics | 3 | 2021 | 8748 | 0.230 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15944 | 0.230 |
Why?
|
| Employee Performance Appraisal | 1 | 2004 | 86 | 0.230 |
Why?
|
| Retinal Diseases | 1 | 2010 | 710 | 0.230 |
Why?
|
| Telemedicine | 3 | 2021 | 3109 | 0.230 |
Why?
|
| Public Health | 3 | 2023 | 2679 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 7470 | 0.230 |
Why?
|
| Developed Countries | 2 | 2019 | 454 | 0.230 |
Why?
|
| Hospitals | 3 | 2018 | 3886 | 0.230 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39345 | 0.230 |
Why?
|
| Quality of Health Care | 2 | 2024 | 4310 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2024 | 6875 | 0.220 |
Why?
|
| Military Medicine | 1 | 2006 | 185 | 0.220 |
Why?
|
| Cultural Diversity | 1 | 2007 | 373 | 0.220 |
Why?
|
| Wit and Humor as Topic | 1 | 2003 | 31 | 0.220 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2012 | 2204 | 0.220 |
Why?
|
| Family Practice | 1 | 2006 | 509 | 0.220 |
Why?
|
| Self-Help Groups | 1 | 2005 | 194 | 0.220 |
Why?
|
| Physical Fitness | 1 | 2008 | 744 | 0.220 |
Why?
|
| Hydroxychloroquine | 1 | 2007 | 426 | 0.210 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 640 | 0.210 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2011 | 1483 | 0.210 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3929 | 0.210 |
Why?
|
| Immunoglobulin G | 3 | 2024 | 4564 | 0.210 |
Why?
|
| Psychotic Disorders | 2 | 2008 | 3276 | 0.210 |
Why?
|
| Muscular Diseases | 1 | 2007 | 553 | 0.210 |
Why?
|
| United States | 12 | 2024 | 73027 | 0.210 |
Why?
|
| Unemployment | 1 | 2024 | 211 | 0.210 |
Why?
|
| Rural Health Services | 1 | 2006 | 394 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
| Mood Disorders | 1 | 2009 | 1129 | 0.200 |
Why?
|
| Automobile Driving | 1 | 2007 | 442 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
| Time Factors | 8 | 2021 | 40214 | 0.200 |
Why?
|
| Poliomyelitis | 2 | 2013 | 91 | 0.200 |
Why?
|
| Physicians | 3 | 2011 | 4598 | 0.200 |
Why?
|
| Body Weight | 2 | 2018 | 4628 | 0.200 |
Why?
|
| Sex Factors | 5 | 2020 | 10627 | 0.190 |
Why?
|
| Anti-HIV Agents | 2 | 2015 | 4573 | 0.190 |
Why?
|
| Diagnosis, Differential | 8 | 2024 | 13000 | 0.190 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 109 | 0.190 |
Why?
|
| Obesity | 1 | 2024 | 13091 | 0.190 |
Why?
|
| Axons | 1 | 2010 | 1677 | 0.190 |
Why?
|
| Mycophenolic Acid | 1 | 2024 | 348 | 0.190 |
Why?
|
| Colchicine | 1 | 2023 | 257 | 0.190 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2450 | 0.190 |
Why?
|
| Immunosuppressive Agents | 3 | 2024 | 4205 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2010 | 2816 | 0.190 |
Why?
|
| Private Sector | 2 | 2015 | 396 | 0.190 |
Why?
|
| Heart Arrest | 1 | 2011 | 1516 | 0.190 |
Why?
|
| Organizations | 1 | 2022 | 172 | 0.190 |
Why?
|
| Mali | 1 | 2021 | 51 | 0.180 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1649 | 0.180 |
Why?
|
| Niger | 1 | 2021 | 38 | 0.180 |
Why?
|
| Vaccination | 3 | 2022 | 3437 | 0.180 |
Why?
|
| Comorbidity | 4 | 2019 | 10590 | 0.180 |
Why?
|
| Encephalomyelitis, Eastern Equine | 1 | 2020 | 14 | 0.180 |
Why?
|
| Community Health Planning | 2 | 2012 | 164 | 0.180 |
Why?
|
| Burkina Faso | 1 | 2021 | 88 | 0.180 |
Why?
|
| Diabetes Complications | 1 | 2007 | 1319 | 0.180 |
Why?
|
| Disease Progression | 5 | 2024 | 13665 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2009 | 711 | 0.180 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 3414 | 0.180 |
Why?
|
| Neisseria meningitidis | 1 | 2021 | 111 | 0.180 |
Why?
|
| Haemophilus influenzae | 1 | 2021 | 177 | 0.180 |
Why?
|
| Salmonella | 1 | 2021 | 125 | 0.180 |
Why?
|
| Spinal Puncture | 2 | 2015 | 286 | 0.170 |
Why?
|
| Lung Transplantation | 1 | 2010 | 1309 | 0.170 |
Why?
|
| Urban Population | 3 | 2022 | 2045 | 0.170 |
Why?
|
| Body Mass Index | 1 | 2018 | 13053 | 0.170 |
Why?
|
| Age Factors | 8 | 2019 | 18407 | 0.170 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 1434 | 0.170 |
Why?
|
| HIV-1 | 1 | 2018 | 6960 | 0.170 |
Why?
|
| Cryptococcus neoformans | 1 | 2021 | 121 | 0.170 |
Why?
|
| Cognition | 3 | 2018 | 7072 | 0.170 |
Why?
|
| Acyclovir | 2 | 2013 | 267 | 0.170 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12075 | 0.170 |
Why?
|
| Apolipoproteins | 1 | 2022 | 328 | 0.170 |
Why?
|
| Hypertension | 4 | 2019 | 8616 | 0.170 |
Why?
|
| Electronics | 1 | 2021 | 317 | 0.170 |
Why?
|
| Japan | 2 | 2016 | 1418 | 0.170 |
Why?
|
| Bangladesh | 2 | 2012 | 742 | 0.170 |
Why?
|
| Survivors | 1 | 2010 | 2381 | 0.170 |
Why?
|
| Schizophrenia | 2 | 2008 | 6983 | 0.170 |
Why?
|
| Corpus Callosum | 2 | 2016 | 753 | 0.170 |
Why?
|
| Cadmium | 1 | 2020 | 217 | 0.160 |
Why?
|
| Prospective Studies | 10 | 2024 | 54924 | 0.160 |
Why?
|
| Lebanon | 1 | 2020 | 245 | 0.160 |
Why?
|
| Health Care Costs | 4 | 2020 | 3239 | 0.160 |
Why?
|
| Recurrence | 6 | 2023 | 8507 | 0.160 |
Why?
|
| Valine | 2 | 2013 | 410 | 0.160 |
Why?
|
| Mental Health | 3 | 2021 | 3275 | 0.160 |
Why?
|
| Medicine, African Traditional | 1 | 2019 | 31 | 0.160 |
Why?
|
| Critical Care | 1 | 2011 | 2715 | 0.160 |
Why?
|
| Health Status | 1 | 2012 | 4092 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2007 | 2024 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 2764 | 0.160 |
Why?
|
| Wechsler Scales | 1 | 2019 | 256 | 0.160 |
Why?
|
| China | 2 | 2016 | 2395 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10396 | 0.160 |
Why?
|
| Infant | 8 | 2019 | 36534 | 0.150 |
Why?
|
| Chad | 1 | 2018 | 9 | 0.150 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2021 | 491 | 0.150 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 14718 | 0.150 |
Why?
|
| Ebolavirus | 1 | 2021 | 250 | 0.150 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2015 | 2596 | 0.150 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 748 | 0.150 |
Why?
|
| Ocular Motility Disorders | 2 | 2009 | 144 | 0.150 |
Why?
|
| Nigeria | 1 | 2021 | 781 | 0.150 |
Why?
|
| Drug Substitution | 1 | 2020 | 291 | 0.140 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.140 |
Why?
|
| Arizona | 1 | 2017 | 108 | 0.140 |
Why?
|
| Blood Platelets | 3 | 2022 | 2479 | 0.140 |
Why?
|
| Air Pollution | 1 | 2011 | 2374 | 0.140 |
Why?
|
| Psychiatry | 1 | 2009 | 1716 | 0.140 |
Why?
|
| Logistic Models | 4 | 2020 | 13289 | 0.140 |
Why?
|
| Psychosocial Deprivation | 1 | 2017 | 101 | 0.140 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2017 | 155 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 1 | 2018 | 159 | 0.140 |
Why?
|
| Age of Onset | 2 | 2016 | 3347 | 0.140 |
Why?
|
| Data Collection | 3 | 2013 | 3326 | 0.130 |
Why?
|
| Peripartum Period | 1 | 2017 | 137 | 0.130 |
Why?
|
| Sodium | 1 | 2021 | 1597 | 0.130 |
Why?
|
| Policy Making | 1 | 2020 | 546 | 0.130 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1713 | 0.130 |
Why?
|
| Singapore | 1 | 2016 | 300 | 0.130 |
Why?
|
| Age Distribution | 2 | 2012 | 2871 | 0.130 |
Why?
|
| Phenytoin | 1 | 2016 | 189 | 0.130 |
Why?
|
| PubMed | 2 | 2017 | 129 | 0.120 |
Why?
|
| Patient Care | 2 | 2014 | 629 | 0.120 |
Why?
|
| India | 2 | 2013 | 2334 | 0.120 |
Why?
|
| Kenya | 1 | 2018 | 757 | 0.120 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2015 | 1903 | 0.120 |
Why?
|
| Activities of Daily Living | 2 | 2019 | 2429 | 0.120 |
Why?
|
| Carbamazepine | 1 | 2016 | 224 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2021 | 764 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2009 | 3301 | 0.120 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 243 | 0.120 |
Why?
|
| Family Characteristics | 1 | 2020 | 1003 | 0.120 |
Why?
|
| Photography | 1 | 2018 | 537 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20757 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3589 | 0.120 |
Why?
|
| Dementia | 1 | 2009 | 2740 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 13499 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 1135 | 0.110 |
Why?
|
| Contraception | 1 | 2017 | 362 | 0.110 |
Why?
|
| Indonesia | 1 | 2014 | 131 | 0.110 |
Why?
|
| Asia, Western | 1 | 2013 | 19 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 4423 | 0.110 |
Why?
|
| Public Sector | 1 | 2015 | 266 | 0.110 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8761 | 0.110 |
Why?
|
| Vasculitis | 1 | 2018 | 525 | 0.110 |
Why?
|
| Valproic Acid | 1 | 2016 | 444 | 0.110 |
Why?
|
| Health Surveys | 3 | 2019 | 4056 | 0.110 |
Why?
|
| Prevalence | 3 | 2020 | 15867 | 0.110 |
Why?
|
| Rabies | 1 | 2013 | 56 | 0.110 |
Why?
|
| Schools | 2 | 2019 | 1498 | 0.110 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 7851 | 0.110 |
Why?
|
| Anxiety | 3 | 2023 | 4672 | 0.110 |
Why?
|
| Financial Support | 1 | 2013 | 116 | 0.110 |
Why?
|
| Melkersson-Rosenthal Syndrome | 1 | 2012 | 1 | 0.100 |
Why?
|
| Government Agencies | 1 | 2013 | 161 | 0.100 |
Why?
|
| Neuropsychological Tests | 3 | 2011 | 7140 | 0.100 |
Why?
|
| South Africa | 4 | 2019 | 1873 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1798 | 0.100 |
Why?
|
| Disaster Medicine | 1 | 2013 | 75 | 0.100 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2012 | 24 | 0.100 |
Why?
|
| Baltimore | 1 | 2013 | 233 | 0.100 |
Why?
|
| Incidence | 3 | 2016 | 21532 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 540 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4289 | 0.100 |
Why?
|
| RNA | 1 | 2022 | 2718 | 0.100 |
Why?
|
| International Cooperation | 1 | 2019 | 1434 | 0.100 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 123 | 0.100 |
Why?
|
| Head | 1 | 2018 | 926 | 0.100 |
Why?
|
| Leprosy | 1 | 2012 | 125 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4978 | 0.100 |
Why?
|
| Hepatitis C | 2 | 2015 | 1594 | 0.100 |
Why?
|
| Poliovirus | 1 | 2012 | 106 | 0.100 |
Why?
|
| Bradycardia | 2 | 2017 | 305 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1883 | 0.090 |
Why?
|
| Environmental Exposure | 2 | 2020 | 4543 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 9116 | 0.090 |
Why?
|
| Meningitis, Bacterial | 1 | 2013 | 225 | 0.090 |
Why?
|
| Syphilis | 1 | 2014 | 243 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2893 | 0.090 |
Why?
|
| Laos | 1 | 2011 | 27 | 0.090 |
Why?
|
| Toes | 1 | 2012 | 209 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1761 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9614 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 1296 | 0.090 |
Why?
|
| Torture | 1 | 2011 | 69 | 0.090 |
Why?
|
| Museums | 1 | 2010 | 23 | 0.090 |
Why?
|
| Social Conditions | 1 | 2011 | 121 | 0.090 |
Why?
|
| Immunization Schedule | 1 | 2012 | 228 | 0.090 |
Why?
|
| Meningitis | 1 | 2012 | 219 | 0.090 |
Why?
|
| Pregnancy Complications | 3 | 2024 | 2972 | 0.090 |
Why?
|
| Social Work | 1 | 2012 | 158 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2015 | 530 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3216 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2017 | 1198 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2010 | 2766 | 0.090 |
Why?
|
| Health Services Research | 1 | 2018 | 1815 | 0.090 |
Why?
|
| Educational Measurement | 2 | 2008 | 1260 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2748 | 0.090 |
Why?
|
| Plant Leaves | 1 | 2010 | 153 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 708 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 6029 | 0.080 |
Why?
|
| Endocarditis | 1 | 2014 | 352 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 3701 | 0.080 |
Why?
|
| Minnesota | 1 | 2010 | 339 | 0.080 |
Why?
|
| Prognosis | 3 | 2017 | 29979 | 0.080 |
Why?
|
| Apnea | 1 | 2011 | 193 | 0.080 |
Why?
|
| Sexuality | 1 | 2011 | 179 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2013 | 470 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5394 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2017 | 1726 | 0.080 |
Why?
|
| Stem Cells | 1 | 2022 | 3537 | 0.080 |
Why?
|
| Gloves, Protective | 1 | 2008 | 23 | 0.080 |
Why?
|
| Disabled Persons | 2 | 2011 | 1210 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2014 | 5349 | 0.080 |
Why?
|
| Cartilage Diseases | 1 | 2010 | 160 | 0.080 |
Why?
|
| Brain Stem Infarctions | 1 | 2009 | 31 | 0.080 |
Why?
|
| Ventricular Fibrillation | 1 | 2011 | 537 | 0.080 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 553 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 5536 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2016 | 8082 | 0.080 |
Why?
|
| Thiamine | 1 | 2009 | 160 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2012 | 463 | 0.080 |
Why?
|
| Saskatchewan | 1 | 2007 | 8 | 0.080 |
Why?
|
| Uganda | 1 | 2013 | 1361 | 0.080 |
Why?
|
| Antiviral Agents | 2 | 2013 | 3073 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6339 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2010 | 714 | 0.080 |
Why?
|
| Community Networks | 1 | 2010 | 202 | 0.070 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 149 | 0.070 |
Why?
|
| Photophobia | 1 | 2008 | 77 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2009 | 185 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 873 | 0.070 |
Why?
|
| Head Injuries, Closed | 1 | 2009 | 133 | 0.070 |
Why?
|
| Pons | 1 | 2009 | 239 | 0.070 |
Why?
|
| Genotype | 1 | 2022 | 13042 | 0.070 |
Why?
|
| Paresis | 1 | 2009 | 177 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 268 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2012 | 26420 | 0.070 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 299 | 0.070 |
Why?
|
| Ataxia | 1 | 2009 | 307 | 0.070 |
Why?
|
| Leg | 1 | 2012 | 1088 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 401 | 0.070 |
Why?
|
| Tongue Diseases | 1 | 2007 | 69 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2012 | 2276 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2011 | 969 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1377 | 0.070 |
Why?
|
| Scleroderma, Localized | 1 | 2007 | 85 | 0.070 |
Why?
|
| Laryngeal Muscles | 1 | 2007 | 107 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 928 | 0.070 |
Why?
|
| Survival Rate | 2 | 2011 | 12828 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1836 | 0.070 |
Why?
|
| Epidemics | 1 | 2012 | 517 | 0.070 |
Why?
|
| Caregivers | 1 | 2019 | 2302 | 0.070 |
Why?
|
| Publications | 1 | 2008 | 195 | 0.070 |
Why?
|
| Health Services | 1 | 2011 | 755 | 0.070 |
Why?
|
| Phenotype | 1 | 2024 | 16723 | 0.070 |
Why?
|
| Hospital Volunteers | 1 | 2005 | 5 | 0.070 |
Why?
|
| Mental Processes | 1 | 2007 | 246 | 0.070 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2008 | 249 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 30211 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2923 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2009 | 497 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1551 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2020 | 3463 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1736 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1034 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4258 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2744 | 0.060 |
Why?
|
| Risk | 2 | 2017 | 9609 | 0.060 |
Why?
|
| Job Application | 1 | 2004 | 38 | 0.060 |
Why?
|
| Pharynx | 1 | 2007 | 436 | 0.060 |
Why?
|
| Behavior | 1 | 2007 | 541 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6071 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2020 | 10098 | 0.060 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2024 | 40 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2011 | 1200 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2741 | 0.060 |
Why?
|
| Thalamus | 1 | 2010 | 1047 | 0.060 |
Why?
|
| Cholesterol | 1 | 2013 | 2914 | 0.060 |
Why?
|
| Tongue | 1 | 2007 | 406 | 0.060 |
Why?
|
| Prejudice | 1 | 2008 | 574 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 1140 | 0.060 |
Why?
|
| Safety | 1 | 2008 | 1159 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3800 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2012 | 1397 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 3813 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1193 | 0.050 |
Why?
|
| Independent Living | 2 | 2018 | 584 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 939 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2015 | 5107 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 14783 | 0.050 |
Why?
|
| Medicine | 1 | 2011 | 945 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2023 | 9384 | 0.050 |
Why?
|
| Viral Load | 1 | 2012 | 3396 | 0.050 |
Why?
|
| Hepatitis B | 1 | 2008 | 711 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 788 | 0.050 |
Why?
|
| Occupational Health | 1 | 2009 | 812 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2023 | 171 | 0.050 |
Why?
|
| Aspirin | 2 | 2019 | 3135 | 0.050 |
Why?
|
| Pregnancy | 3 | 2024 | 30260 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 1789 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4415 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2708 | 0.050 |
Why?
|
| France | 1 | 2003 | 497 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2009 | 6668 | 0.050 |
Why?
|
| Attitude to Death | 1 | 2005 | 400 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20218 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 643 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1226 | 0.050 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2021 | 19 | 0.050 |
Why?
|
| Physician-Patient Relations | 2 | 2005 | 3269 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6211 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2012 | 2880 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2012 | 3583 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 2029 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2023 | 563 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2023 | 336 | 0.050 |
Why?
|
| Acute Disease | 2 | 2010 | 7241 | 0.050 |
Why?
|
| Confusion | 1 | 2023 | 278 | 0.040 |
Why?
|
| Counseling | 1 | 2008 | 1554 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 9016 | 0.040 |
Why?
|
| Culture | 1 | 2003 | 622 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2013 | 5952 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2010 | 3113 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22287 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1674 | 0.040 |
Why?
|
| Leukocytes | 1 | 2007 | 2035 | 0.040 |
Why?
|
| Length of Stay | 1 | 2013 | 6495 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 373 | 0.040 |
Why?
|
| ROC Curve | 2 | 2020 | 3628 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2023 | 891 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1892 | 0.040 |
Why?
|
| Smoking | 1 | 2015 | 9089 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 1536 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 2194 | 0.040 |
Why?
|
| Memory | 1 | 2007 | 2208 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2013 | 8540 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2007 | 1381 | 0.040 |
Why?
|
| Social Isolation | 1 | 2020 | 366 | 0.040 |
Why?
|
| Pain | 1 | 2012 | 5100 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15442 | 0.030 |
Why?
|
| Antibodies, Helminth | 1 | 2016 | 59 | 0.030 |
Why?
|
| Antigens, Helminth | 1 | 2016 | 69 | 0.030 |
Why?
|
| Sclerosis | 1 | 2017 | 211 | 0.030 |
Why?
|
| Taenia solium | 1 | 2016 | 28 | 0.030 |
Why?
|
| Transportation | 1 | 2018 | 217 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 820 | 0.030 |
Why?
|
| Weight Gain | 1 | 2006 | 2359 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2020 | 905 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 392 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 24314 | 0.030 |
Why?
|
| Creatinine | 1 | 2020 | 1918 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 1001 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2008 | 6411 | 0.030 |
Why?
|
| Occupations | 1 | 2016 | 516 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2021 | 2201 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1587 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 810 | 0.030 |
Why?
|
| Thrombosis | 1 | 2007 | 2957 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3210 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2009 | 4854 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 158 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2166 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2013 | 574 | 0.020 |
Why?
|
| Reflex, Abnormal | 1 | 2011 | 83 | 0.020 |
Why?
|
| Palliative Care | 1 | 2006 | 3642 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 571 | 0.020 |
Why?
|
| Folic Acid | 1 | 2017 | 1337 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2533 | 0.020 |
Why?
|
| Granuloma | 1 | 2012 | 329 | 0.020 |
Why?
|
| Medical Futility | 1 | 2011 | 136 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4904 | 0.020 |
Why?
|
| Life Support Care | 1 | 2011 | 226 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 962 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2029 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8740 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3110 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13658 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 823 | 0.020 |
Why?
|
| Amnesia | 1 | 2010 | 257 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2665 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3237 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2448 | 0.020 |
Why?
|
| Inflammation | 1 | 2007 | 10871 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3948 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2023 | 4857 | 0.020 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2010 | 279 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1474 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1142 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2011 | 580 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3271 | 0.020 |
Why?
|
| Brain Stem | 1 | 2011 | 859 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3773 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2017 | 1885 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21206 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4857 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 983 | 0.010 |
Why?
|
| Sleep | 1 | 2020 | 4817 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3568 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2271 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 2008 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5887 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6786 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4884 | 0.010 |
Why?
|
| Attention | 1 | 2010 | 2424 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 14163 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5330 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4503 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6685 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2012 | 5130 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10840 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 169222 | 0.000 |
Why?
|